Stanley Chesley, a pioneer and long-dominant force in class-action lawsuits whose five-decade legal career ended after ...
Kimberly-Clark is buying Tylenol maker Kenvue in an approximately $48.7 billion cash-and-stock deal, creating a massive consumer health goods company. Kenvue shareholders will receive $3.50 per share ...